Metraipolis › archive › dc_7a101bdf27bf

The novel GLP-1/GIP dual receptor agonist DA5-CH is superior to tirzepatide and exendin-4 in the 6-OHDA Parkinson rat model — Europe PMC PMID:42165019

Source: Europe PMC (en)
Original: https://europepmc.org/article/MED/42165019
DOI: 10.3389/fendo.2026.1825379
License (as archived): solo-consultazione
Archived: 2026-11-02T18:00:26.795Z
SHA-256 of the archived text: 31fc0f34636e0eccd5d491cc52c9daf8faefed07f64e4fa4677c3f3ea7656c7a
Stable URL of this page: https://metraipolis.com/documento/dc_7a101bdf27bf

How to cite

The novel GLP-1/GIP dual receptor agonist DA5-CH is superior to tirzepatide and exendin-4 in the 6-OHDA Parkinson rat model — Europe PMC PMID:42165019 — Europe PMC (en), https://europepmc.org/article/MED/42165019 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_7a101bdf27bf (Metraipolis archive dc_7a101bdf27bf, sha256 31fc0f34636e0eccd5d491cc52c9daf8faefed07f64e4fa4677c3f3ea7656c7a)

BibTeX

@misc{dc7a101bdf27bf,
  title = {The novel GLP-1/GIP dual receptor agonist DA5-CH is superior to tirzepatide and exendin-4 in the 6-OHDA Parkinson rat model — Europe PMC PMID:42165019},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/42165019},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_7a101bdf27bf; sha256 31fc0f34636e0eccd5d491cc52c9daf8faefed07f64e4fa4677c3f3ea7656c7a},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42165019. Agents can read the archived copy with the MCP tool read_document.